Facebook
Twitter
Telegram
Report an ErrorTonix Pharmaceuticals Holding Corp. Financial Ratios 2011-2024 | TNXP
Annual Financial Ratios Tonix Pharmaceuticals Holding Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.0 | -0.9 | -2.5 | -0.1 | -0.1 | -1.3 | -0.4 | -1.7 | -2.3 | -4.4 | - | - |
P/S |
0.4 | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-6.8 | -20.0 | -8.1 | -0.6 | -19.3 | -259.9 | -31.7 | -15.4 | -28.6 | -2.8 | -3.4 | -5.6 | -3.2 |
EV (Enterprise Value) |
27.2 M | -97.7 M | -69 M | 58.1 M | -3.98 M | -20.2 M | 3.44 M | -2.42 M | 68.8 M | 27.6 M | 41.6 M | -627 K | 2.84 M |
EBITDA per Share |
-6.7 | -19 | -8.1 | -0.397 | -17.9 | -240 | -318 | -1.54 K | -2.86 K | -2.77 K | -3.36 K | - | - |
EV/EBITDA |
-25.6 | -0.9 | 0.3 | 0.9 | -0.1 | 0.1 | -1.3 | -0.9 | -3.6 | 0.2 | - | ||
PEG |
-0.0 | -0.0 | -0.0 | 0.04 | -0.0 | -0.01 | -0.02 | -0.01 | 0.52 | -0.13 | -0.11 | - | - |
P/B |
0.0 | 0.0 | 0.4 | 1.4 | 0.2 | 0.1 | 1.1 | 0.6 | 2.0 | 1.7 | 7.3 | - | - |
P/CF |
-0.0 | -0.0 | -1.2 | -2.2 | -0.1 | -0.1 | -1.4 | -0.4 | -1.9 | -2.7 | -5.6 | - | - |
ROE % |
-110.55 | -53.20 | -42.19 | -57.57 | -303.90 | -110.25 | -85.81 | -153.16 | -119.35 | -76.52 | -167.14 | -984.38 | - |
ROA % |
-75.53 | -48.84 | -38.31 | -51.40 | -196.58 | -99.13 | -78.95 | -141.19 | -102.20 | -69.84 | -124.59 | -445.75 | - |
ROCE % |
-112.18 | -54.10 | -42.21 | -57.16 | -305.93 | -111.23 | -86.45 | -153.46 | -119.31 | -76.48 | -166.87 | -964.29 | - |
Current Ratio |
3.2 | 12.2 | 10.9 | 9.0 | 2.7 | 9.8 | 12.4 | 12.8 | 7.0 | 11.5 | 3.9 | 1.8 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
525.0 | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
456.2 | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
525.0 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
68.9 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Tonix Pharmaceuticals Holding Corp.
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.18 | - | -1.83 | -2.68 | -3.21 | - | -4.24 | -7.64 | -1.61 | - | -1.6 | -2.25 | -0.07 | - | -0.09 | -0.23 | -0.37 | - | -5.69 | -9.42 | -12.76 | - | -54.99 | -7.23 | -8.8 | - | -0.77 | -0.65 | -1.27 | - | -2.9 | -4.97 | -7.41 | -0.71 | -0.72 | -0.73 | -0.71 | -0.83 | -0.71 | -0.61 | -0.59 | - | -0.87 | -0.95 | -0.93 | - | -0.05 | -1.01 | -1.27 | - | -0.05 | -0.02 | -0.03 |
EBITDA per Share |
-0.25 | - | -1.77 | -2.65 | -3.21 | - | -4.29 | -6.48 | -1.6 | - | -1.6 | -2.25 | -0.07 | - | -0.09 | -0.23 | -0.3 | - | -5.71 | -9.5 | -12.9 | - | -55.2 | -7.26 | -8.85 | - | -0.77 | -0.65 | -1.27 | - | -2.9 | -4.97 | -7.4 | -7.12 | -0.72 | -0.73 | -0.71 | -0.83 | -0.71 | -0.61 | -0.59 | - | -0.87 | -0.95 | -0.92 | - | -0.05 | -1.01 | -0.73 | - | -0.05 | -0.02 | -0.02 |
ROE % |
-80.31 | -63.29 | -75.95 | -65.46 | -55.41 | -35.50 | -44.66 | -41.16 | -44.08 | -33.89 | -47.57 | -52.08 | -55.21 | -38.15 | -121.39 | -190.94 | -236.78 | -211.44 | -234.59 | -174.51 | -138.22 | -78.18 | -101.69 | -102.04 | -95.73 | -63.50 | -93.38 | -99.75 | -119.00 | -123.65 | -156.84 | -159.87 | -150.42 | -119.35 | -111.08 | -98.72 | -86.25 | -76.52 | -99.06 | -125.96 | -141.24 | -110.21 | -290.87 | -424.09 | -572.72 | -571.50 | -530.16 | -308.16 | -113.00 | 76.77 | 41.34 | 14.50 | 20.93 |
ROA % |
-68.96 | -56.27 | -68.21 | -60.07 | -50.70 | -32.13 | -40.76 | -37.44 | -41.51 | -32.33 | -44.54 | -48.13 | -50.12 | -34.06 | -87.90 | -129.53 | -155.20 | -136.77 | -157.59 | -124.57 | -107.58 | -70.30 | -91.92 | -92.73 | -87.47 | -58.42 | -85.97 | -91.89 | -109.67 | -113.99 | -142.41 | -143.04 | -132.42 | -102.20 | -96.52 | -87.10 | -77.37 | -69.84 | -82.48 | -99.09 | -107.68 | -82.15 | -163.96 | -210.40 | -268.33 | -258.79 | -497.24 | -653.88 | -655.71 | -442.82 | -238.45 | -83.63 | -120.73 |
ROCE % |
-86.98 | -64.44 | -77.36 | -66.99 | -56.57 | -35.86 | -45.03 | -41.27 | -44.10 | -33.94 | -47.63 | -52.16 | -55.29 | -38.21 | -122.00 | -192.11 | -238.63 | -213.38 | -236.80 | -176.42 | -139.66 | -78.90 | -102.61 | -102.90 | -96.53 | -63.97 | -93.98 | -100.28 | -119.47 | -124.04 | -157.33 | -160.31 | -150.80 | -119.62 | -111.28 | -98.90 | -86.39 | -76.63 | -99.16 | -126.04 | -141.32 | -110.24 | -291.15 | -424.57 | -573.44 | -482.84 | -441.50 | -219.26 | -23.85 | 76.78 | 41.34 | 14.50 | 20.93 |
Current Ratio |
5.0 | 3.2 | 7.5 | 8.3 | 13.1 | 12.2 | 17.7 | 16.9 | 14.2 | 10.9 | 17.1 | 21.8 | 27.8 | 9.3 | 9.3 | 9.3 | 9.3 | 2.8 | 2.8 | 2.8 | 2.8 | 9.9 | 9.9 | 9.9 | 9.9 | 12.5 | 12.5 | 12.5 | 12.5 | 12.8 | 12.8 | 12.8 | 12.8 | 7.0 | 7.0 | 7.0 | 7.0 | 11.5 | 11.5 | 11.5 | 11.5 | 3.9 | 3.9 | 3.9 | 3.9 | 1.8 | 1.8 | 1.8 | 1.8 | 0.1 | 0.1 | 0.1 | 0.1 |
DSO |
- | - | 17.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
714.3 | - | 519.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
286.7 | - | 297.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
714.3 | - | 537.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
427.6 | - | 239.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency